Our Team

Board of Directors

Katherine Davis

Katherine L. Davis

Chairperson

Katherine Davis joined the Board of Directors in May 2007. Ms. Davis is presently the owner of Davis Design Group LLC…

View Full Bio

Katherine Davis joined the Board of Directors in May 2007. Ms. Davis is presently the owner of Davis Design Group LLC., a company that provides analytical and visual tools for public policy design. Previously, she was CEO of Global Access Point, a company with products for data transport, data processing, and data storage network and hub facilities. Ms. Davis held a number of government positions, including Lieutenant Governor of the State of Indiana and Controller of the City of Indianapolis. Ms. Davis serves on the not-for-profit boards of Noble of Indiana, Lumina Foundation for Education, Indianapolis Foundation, Central Indiana Community Foundation, Western Governors University Indiana, and Indiana University School of Public and Environmental Affairs. She has a B.S. in Mechanical Engineering from the Massachusetts Institute of Technology and an M.B.A. from Harvard Business School.

Mary Lake Polan

Mary Lake Polan, M.D., Ph.D., M.P.H.

Dr. Polan joined the Board of Directors in August 2018. She is a Professor of Clinical Obstetrics, Gynecology and Reproductive Sciences…

View Full Bio

Dr. Polan joined the Board of Directors in August 2018. She is a Professor of Clinical Obstetrics, Gynecology and Reproductive Sciences at the Yale University School of Medicine, where her work focuses on reproductive health for women. She is a renowned women’s health researcher. Dr. Polan has significant experience in leadership roles at several medical schools, and prior to Yale she served as an Adjunct Professor in the Obstetrics and Gynecology department at Columbia University School of Medicine. Previously Dr. Polan spent 15 years as the Chair of the Department of Obstetrics and Gynecology at Stanford University School of Medicine. Dr. Polan also currently serves on the board of Quidel Corp., and Motif BioSciences, Inc. and is the Chair of the Procter & Gamble Scientific Advisory Board on Women’s Health and Hygiene. She received her Ph.D. and M.D. from Yale University, and M.P.H. from University of California at Berkeley.

John Potthoff

John G. Potthoff, Ph.D

Dr. Potthoff joined the Board of Directors in May 2018. He has 25 years of experience in the clinical research services industry…

View Full Bio

Dr. Potthoff joined the Board of Directors in May 2018. He has 25 years of experience in the clinical research services industry, with deep ties to diagnostics and pharmaceutical companies. He is currently the CEO of Elligo Health Research, a clinical research company aimed at being the preeminent provider of clinical research infrastructure services and technologies. Prior to Elligo, Dr. Potthoff was the CEO of Theorem Clinical Research, where he led the company through a period of significant growth and its acquisition by Chiltern International. Previously, Dr. Potthoff was the CEO and founder of Tanistry, Inc., a contract research organization focused on the central nervous system. Dr. Potthoff also currently sits on the boards of Advarra and SynteractHCR and was previously a director at Chiltern until its acquisition by LabCorp in 2017. He received his Ph.D. in Psychology from the University of Texas-Austin, where he also received his Bachelor of Arts and Master of Arts, also in Psychology.

Richard Eberly

Richard L. Eberly

Richard Eberly joined Chembio in March, 2020. Most recently, he was the Managing Director at Solid Rock Principled Capital…

View Full Bio

Richard Eberly joined Chembio in March, 2020. Most recently, he was the Managing Director at Solid Rock Principled Capital, a healthcare focused private equity firm. He was instrumental in developing strategy and optimizing operations for the firm. Prior to Solid Rock, Richard held various roles of increasing responsibility with over 23 years at Meridian Bioscience Inc., ultimately serving as the company’s President and Chief Commercial Officer. Meridian Bioscience is a life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. Under his leadership the company successfully grew sales, improved operations and profitability, launched significant new product lines and completed several acquisitions. He began his career at Abbott Diagnostics. Richard received a B.S. in Biochemistry from Juniata College and an M.B.A. from Xavier University.

Management Team

Richard Eberly

Richard L. Eberly

President,
Chief Executive Officer

Richard Eberly joined Chembio in March, 2020. Most recently, he was the Managing Director at Solid Rock Principled Capital…

View Full Bio

Richard Eberly joined Chembio in March, 2020. Most recently, he was the Managing Director at Solid Rock Principled Capital, a healthcare focused private equity firm. He was instrumental in developing strategy and optimizing operations for the firm. Prior to Solid Rock, Richard held various roles of increasing responsibility with over 23 years at Meridian Bioscience Inc., ultimately serving as the company’s President and Chief Commercial Officer. Meridian Bioscience is a life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. Under his leadership the company successfully grew sales, improved operations and profitability, launched significant new product lines and completed several acquisitions. He began his career at Abbott Diagnostics. Richard received a B.S. in Biochemistry from Juniata College and an M.B.A. from Xavier University.

Neil Goldman

Neil A. Goldman, CPA

Executive Vice President,
Chief Financial Officer

Mr. Goldman joined Chembio in December 2017. Most recently, he served as Executive VP-Corporate Development & CFO of J.S.C…

View Full Bio

Mr. Goldman joined Chembio in December 2017. Most recently, he served as Executive VP-Corporate Development & CFO of J.S. Held, a private equity-sponsored national consulting firm. Previously, he held EVP, COO, and CFO positions at Unwired Technology and then joined Delphi Corp., now Aptiv plc (NYSE: APTV), as a Global Finance Director following Delphi’s acquisition of Unwired. Unwired was a tier-1 automotive electronics manufacturer and portfolio company of American Capital. Prior to Unwired, Mr. Goldman served as CFO of EPPCO Enterprises. From 1989 to 2002, he worked as an auditor and advanced into regional and national management consulting roles at Ernst & Young and Cap Gemini Ernst & Young. Mr. Goldman received a B.S. in Business-Accountancy from Miami University, Oxford, OH.

Javan Esfandiari

Javan Esfandiari

Executive Vice President,
Chief Science and Technology Officer

Javan Esfandiari joined Chembio Diagnostic Systems, Inc. in February 2000, and serves as Chief Science and Technology Officer…

View Full Bio

Javan Esfandiari joined Chembio Diagnostic Systems, Inc. in February 2000, and serves as Chief Science and Technology Officer. Prior to joining the company, Mr. Esfandiari co-founded Sinovus Biotech AB, a Swedish biotech company where he served as Director of R&D until Chembio acquired Sinovus. He previously served as Director of R&D for On-Site Biotech. Mr. Esfandiari is the inventor of Chembio’s patented Dual Path Platform (DPP®) technology and developed more than 30 rapid point-of-care diagnostic products in the human and veterinary fields. Mr. Esfandiari received a B.S. in Clinical Chemistry and studied to M. Sc. Level in Molecular Biology from Lund University, Sweden.

Robert Passes

Robert Passas Ph.D.

Vice President,
International Sales and Business Development

Robert Passas joined Chembio Diagnostic Systems, Inc. in October, 2016 and serves as VP of International Sales…

View Full Bio

Robert Passas joined Chembio Diagnostic Systems, Inc. in October, 2016 and serves as VP of International Sales and Business Development focusing on international sales, developing our international distribution partners with a focus on Europe, Japan, and Asia. Prior to Chembio, Robert held various senior leadership roles in IVD companies including as Board Member and Global Commercial Director at the Birmingham, UK based Binding Site; the US San Diego based Quidel where he was Senior Director for International Commercial Operations; Trinity Biotech, Ireland and Abbott Laboratories Diagnostics Division, Wiesbaden. Robert Passas trained in Medical Laboratory Science, within the UK NHS and went on to study Medical Biochemistry at Surrey University. He gained a BSc (hons) degree in 1982 and in 1990 a PhD in Analytical Chemistry, developing novel diagnostics used in clinical research into the complications of diabetes.

Tom Ippolito

Tom Ippolito

Vice President,
Quality and Regulatory Affairs

Tom Ippolito joined Chembio Diagnostic Systems, Inc. in June 2005, and serves as Vice President, Quality and Regulatory Affairs…

View Full Bio

Tom Ippolito joined Chembio Diagnostic Systems, Inc. in June 2005, and serves as Vice President, Quality and Regulatory Affairs. Prior to joining the company, Mr. Ippolito served as Vice President, Regulatory and Quality at Biospecifics Technologies. He previously held a number of positions with United Biomedical, Biospecifics, Merck, Rhone Merieux, Organon Teknika, Analytab Products Inc., and Olympus. Mr. Ippolito holds the position of Course Director of the Fundamentals of Bioscience Program at the State University of Stony Brook and is the instructor for clinical development and regulatory affairs.

Charles Caso

Charles Caso

Vice President,
Sales and Marketing

Charles Caso joined Chembio Diagnostic Systems, Inc. on Monday, June 1, 2020 as VP of Sales & Marketing….

View Full Bio

Charles Caso joined Chembio Diagnostic Systems, Inc. on Monday, June 1, 2020 as VP of Sales & Marketing. Charles has over 25 years of experience in sales and marketing and a proven track record within diagnostics, life science and reference laboratory markets. Prior to joining Chembio, Charles was Vice President of Global Sales and Customer Success at ArcherDx. Prior to that, Charles served as Senior Vice President of Commercial Operations, Global Diagnostics at Meridian Bioscience. He also worked at Beckman Coulter Genomics (Danaher Inc), Quest Diagnostics, and Abbott Diagnostics. Charles received a B.S. from Indiana University of Pennsylvania and a M.B.A. from University of Pittsburgh.

Paul Angelico

Paul J. Angelico

Vice President,
Global Operations

Paul J. Angelico joined Chembio Diagnostic Systems, Inc. in October of 2019 as Vice President of Manufacturing Operations…

View Full Bio

Paul J. Angelico joined Chembio Diagnostic Systems, Inc. in October of 2019 as Vice President of Manufacturing Operations. Mr. Angelico has proven business leadership, startup experience and turnaround experience in previous roles as Executive Vice President of Global Operations at US Nonwovens Inc., a consumer goods manufacturer of cleaning products and detergents and as President of Twin Rivers Technologies, a manufacturer/distributor of personal care products and food and chemical ingredients, which he cofounded. He was also CEO of Aurora Algae, a nutriceutical and pharmaceuticals supplements producer and of Cyclica, a big data predictive analytics developer for the pharmaceutical industry. He has led four successful turnarounds in the healthcare, transportation and specialty chemicals sectors. Mr. Angelico received a BS in Mechanical Engineering from Worcester Polytechnic Institute and completed MBA courses at Babson College.

We are looking for talented, dedicated people wishing to contribute to our common vision of enhancing the health and well being of people worldwide.